The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TXG FINANCIAL STATEMENTS

10X Genomics Inc — balance sheet, income statement and cash flow trends

TXG10X Genomics Inc

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue616.9 M $Gross Profit432 M $ · 70%Operating Income-88.4 M $ · -14%Pre-tax Income-74.9 M $ · -12%Net Income to Owners-75.1 M $ · -12%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue616.9 M $-4.3%
Gross Profit432 M $-3.5%
Operating Income-88.4 M $—
EBITDA28 M $—
Net Income to Owners-75.1 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1 B
  • Equity825.5 M $80%
  • Current Liabilities118.5 M $12%
  • Long-term Liabilities86 M $8%

Key Figures

YoY change
Total Assets1 B $+5.1%
Total Liabilities204.5 M $-1.1%
Total Equity825.5 M $+6.8%
Cash & ST Investments552 M $+23.4%
Total Debt78.8 M $-9.2%
Net Debt-423.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M127.1 M $Operating-19.7 M $Investing-2.5 M $Financing104.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow127.1 M $+89.8%
Capital Expenditures5.6 M $-43.9%
Free Cash Flow121.4 M $+113.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TXG

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.